India vs Uzbekistan: Previously treated cases tested for RR-/MDR-TB
India
86.0%
in 2024
Uzbekistan
86.0%
in 2024
India rank
97th
Uzbekistan rank
97th
Previously treated cases tested for RR-/MDR-TB over time
- India
- Uzbekistan
How they compare
India currently reports 86.0% against 86.0% in Uzbekistan, a difference of 0.0%.
The two have swapped places 2 times across 14 shared years of data; in 2007 it was Uzbekistan ahead.
India ranks 97th and Uzbekistan ranks 97th of 180 countries.
Uzbekistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | India | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.6% | 16.4% | 15.8% | Uzbekistan |
| 2010s | 72.2% | 78.8% | 6.7% | Uzbekistan |
| 2020s | 84.2% | 97.2% | 13.0% | Uzbekistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, India or Uzbekistan?
- India, at 86.0% against 86.0% in Uzbekistan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between India and Uzbekistan?
- 0.0%, with India ahead.
- How many years of comparable data are there for India and Uzbekistan?
- 14 years are reported by both, from 2007 to 2024.
- How do India and Uzbekistan rank globally for previously treated cases tested for rr-/mdr-tb?
- India ranks 97th and Uzbekistan ranks 97th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.